Cti Biopharma Corp

JPMORGAN CHASE & CO

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/18/2023

Shares

1,124,714

Value ($000)

4,724

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/18/2023	4,724	0.0%	1,124,714	3/31/2023
2022 Q4	2/13/2023	7,128	0.0%	1,186,030	12/31/2022
2022 Q3	11/14/2022	6,630	0.0%	1,139,110	9/30/2022
2022 Q2	8/11/2022	6,996	0.0%	1,171,774	6/30/2022
2022 Q1	5/11/2022	18	0.0%	3,872	3/31/2022
2021 Q4	2/11/2022	21	0.0%	8,303	12/31/2021
2021 Q3	11/12/2021	21	0.0%	7,283	9/30/2021
2021 Q2	8/12/2021	24	0.0%	9,539	6/30/2021
2021 Q1	5/12/2021	22	0.0%	7,601	3/31/2021
2020 Q4	2/19/2021	27	0.0%	8,500	12/31/2020
2020 Q3	11/12/2020	9	0.0%	8,538	9/30/2020
2020 Q2	8/11/2020	10	0.0%	8,539	6/30/2020
2020 Q1	5/12/2020	8	0.0%	8,500	3/31/2020
2019 Q4	2/11/2020	255	0.0%	161,661	12/31/2019